Innovative Vaccines and Technologies to Address Tropical Parasitic Diseases
A Special Issue of Vaccines (ISSN 2076-393X) belonging to the section "Vaccines Against Tropical and Other Infectious Diseases".
Deadline for manuscript submissions: 30 April 2027 | Viewed by 1473
Editors
Interests: Chagas disease; Trypanosoma cruzi; vaccine development; biotechnological approaches; drug repurposing; host–pathogen interfence; immune response;parasite gene-deletion
Interests: Trypanosoma cruzi; adjuvant; prophilactic vaccine; terapeutic vaccine; immune response; biomarkers
Interests: Chagas disease; host–parasite interactions; immune evasion; parasite dormancy; light-sheet microscopy; expansion microscopy; skeletal muscle infection; therapeutic development
Special Issue Information
Dear Colleagues,
Tropical parasitic diseases significantly impact global health, particularly in endemic regions where access to prevention and treatment is limited. These infections, caused by complex eukaryotic pathogens such as Trypanosoma cruzi, Leishmania spp., and Plasmodium spp., present unique immunological and biological challenges that complicate traditional vaccine approaches. Developing safe, effective, and accessible vaccines is essential to reducing morbidity, preventing transmission, and contributing to long-term disease control and eventual elimination.
This Special Issue aims to feature innovative scientific advances in vaccine research for tropical parasitic diseases. We invite original research articles and comprehensive reviews that cover topics such as antigen discovery, chimeric and multi-epitope vaccine design, novel adjuvants, immunomodulatory strategies, host–parasite interactions, and biotechnology-based delivery platforms. This Special Issue seeks to advance the field and promote the creation of next-generation vaccines with a significant global impact.
We look forward to receiving your contributions.
Dr. Cecilia Maria Perez Brandan
Dr. Iván Sergio Marcipar
Dr. Fernando Sanchez-Valdez
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- tropical parasitic diseases
- vaccine development
- chimeric and multiepitope vaccines
- immunomodulation and adjuvants
- host–parasite interaction
- biotechnology-based vaccine platforms
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
